DiBiase Mary
Insider CIK 1880179 · XFOR Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-02-12 | 2025-02-14 | 650,000 | — | $0 | 1,140,980 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2025-01-24 | 2025-01-27 | 22,258 | $0.45 | $10.0K | 490,980 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-01-23 | 2025-01-27 | 61,178 | — | $0 | 513,238 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-10-07 | 2024-10-08 | 67,695 | $0.57 | $38.6K | 452,060 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-10-04 | 2024-10-08 | 230,645 | — | $0 | 519,755 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-09-09 | 2024-09-11 | 2,642 | $0.66 | $1.7K | 289,110 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-03-11 | 2024-03-11 | 15,409 | $0.88 | $13.6K | 291,752 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2024-02-13 | 2024-02-16 | 428,248 | — | $0 | 428,248 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2024-02-12 | 2024-02-12 | 3,683 | $1.01 | $3.7K | 307,161 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-11-01 | 2023-11-03 | 67,695 | $0.73 | $49.4K | 310,844 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-10-31 | 2023-11-02 | 230,645 | — | $0 | 378,539 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-09-08 | 2023-09-12 | 2,642 | $1.25 | $3.3K | 147,894 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-06-30 | 2023-07-05 | 464 | $1.89 | $877 | 150,536 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-06-23 | 2023-06-26 | 857 | $1.93 | $1.7K | 151,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-06-15 | 2023-06-16 | 857 | $2.23 | $1.9K | 151,857 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-03-10 | 2023-03-13 | 18,192 | $0.84 | $15.3K | 152,714 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2023-02-13 | 2023-02-15 | 4,348 | $0.93 | $4.0K | 170,906 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2022-11-07 | 2022-11-09 | 1,350,000 | — | $0 | 1,350,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-08-17 | 2022-08-19 | 1,713 | — | $0 | 177,896 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-06-30 | 2022-07-01 | 1,578 | — | $0 | 179,609 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-06-24 | 2022-06-27 | 856 | — | $0 | 181,187 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-06-16 | 2022-06-17 | 856 | — | $0 | 182,043 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-03-01 | 2022-03-01 | 105,000 | — | $0 | 182,899 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-02-11 | 2022-02-14 | 12,545 | — | $0 | 77,899 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2021-09-08 | 2021-09-10 | 27,000 | — | $0 | 90,444 | SEC↗ |